The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their […]
The partnership will concentrate on the development of two investigational antibodies
Move represents the latest phase of preparation for the opening of MSD’s new UK Discovery Centre
Updated Date: Wed, 01 Mar 2023 00:00:00 EST
Updated Date: Wed, 01 Mar 2023 00:00:00 EST
Updated Date: Wed, 01 Mar 2023 00:00:00 EST
Updated Date: Wed, 01 Mar 2023 00:00:00 EST
Updated Date: Wed, 01 Mar 2023 00:00:00 EST
A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence […]
